1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. UROGEN PHARMA LTD
UroGen Pharma Ltd
XNAS: URGN
42.50 0.44 (1.05%)
494.5K
XNAS Volume

XNAS 23 Jul, 2026 4:17 PM (EDT)

Watchlist

Portfolio

Alert

UroGen Pharma Ltd - URGN - stock price prediction, stock price target, analyst ratings from 8 analysts

UroGen Pharma Ltd has a share price target of US$ 45, revenue growth forecast of 151.8%, and profit growth estimate of 76.3% for FY26, based on top 8 analyst calls.